10/13/2011
The limitations of progression-free survival as an endpoint – NPR addresses
7/1/2011
Emotion, anecdotes, politics and ugliness in Avastin aftermath
6/28/2011
Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer